Avanafil 50 mg | 99.66%
TargetMol
Avanafil is a selective inhibitor of phosphodiesterase type 5 (PDE5) and is used as therapy of erectile dysfunction.
More Information Supplier PageAvanafil
Search Results
Avanafil 100 mg | 99.66%
TargetMol
Avanafil is a selective inhibitor of phosphodiesterase type 5 (PDE5) and is used as therapy of erectile dysfunction.
More Information Supplier PageAvanafil
Efinaconazole 5 mg | 99.70%
TargetMol
Efinaconazole(KP-103) is an Azole Antifungal currently under development as a topical treatment for onychomycosis.
More Information Supplier PageEfinaconazole
Raltegravir 25 mg | 99.05%
TargetMol
Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.
More Information Supplier PageRaltegravir
Raltegravir 10 mg | 99.05%
TargetMol
Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.
More Information Supplier PageRaltegravir
JNJ-7777120 5 mg | Purity Not Available
TargetMol
JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.
More Information Supplier PageJNJ-7777120
JNJ-7777120 50 mg | Purity Not Available
TargetMol
JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.
More Information Supplier PageJNJ-7777120
JNJ-7777120 10 mg | Purity Not Available
TargetMol
JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.
More Information Supplier PageJNJ-7777120
JNJ-7777120 100 mg | Purity Not Available
TargetMol
JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.
More Information Supplier PageJNJ-7777120
Raltegravir 50 mg | 99.05%
TargetMol
Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.
More Information Supplier PageRaltegravir